Analyzing histopathological features of rare Charcot-Marie-Tooth neuropathies to unravel their pathogenesis

Sara Benedetti, Stefano Carlo Previtali, Silvia Coviello, Marina Scarlato, Federica Cerri, Emanuela Di Pierri, Lara Piantoni, Ivana Spiga, Raffaella Fazio, Nilo Riva, Maria Grazia Natali Sora, Patrizia Dacci, Maria Chiara Malaguti, Elisabetta Munerati, Luigi Maria Edoardo Grimaldi, Maria Giovanna Marrosu, Maurizio De Pellegrin, Maurizio Ferrari, Giancarlo Comi, Angelo QuattriniAlessandra Bolino

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

Background: Charcot-Marie-Tooth (CMT) neuropathies are very heterogeneous disorders from both a clinical and genetic point of view. The CMT genes identified so far encode different proteins that are variably involved in regulating Schwann cells and/or axonal functions. However, the function of most of these proteins still remains to be elucidated. Objective: To characterize a large cohort of patients with demyelinating, axonal, and intermediate forms of CMT neuropathy. Design: A cohort of 131 unrelated patients were screened for mutations in 12 genes responsible for CMT neuropathies. Demyelinating, axonal, and intermediate forms of CMT neuropathy were initially distinguished as usual on the basis of electrophysiological criteria and clinical evaluation. A sural nerve biopsy was also performed for selected cases. Accordingly, patients underwent first-level analysis of the genes most frequently mutated in each clinical form of CMT neuropathy. Results: Although our cohort had a particularly high percentage of cases of rare axonal and intermediate CMT neuropathies, we found mutations in 40% of patients. Among identified changes, 7 represented new mutations occurring in the MPZ, GJB1, EGR2, MFN2, NEFL, and HSBP1/HSP27 genes. Histopathological analysis performed in selected cases revealed morphological features, which correlated with the molecular diagnosis and provided evidence of the underlying pathogenetic mechanism. Conclusion: Clinical and pathological analysis of patients with CMT neuropathies contributes to our understanding of the molecular mechanisms of CMT neuropathies.

Original languageEnglish
Pages (from-to)1498-1505
Number of pages8
JournalArchives of Neurology
Volume67
Issue number12
DOIs
Publication statusPublished - Dec 2010

Fingerprint

Tooth
Mutation
Genes
Teeth
Sural Nerve
Schwann Cells
Proteins
Biopsy
Gene
Intermediate
Cohort

ASJC Scopus subject areas

  • Clinical Neurology

Cite this

Analyzing histopathological features of rare Charcot-Marie-Tooth neuropathies to unravel their pathogenesis. / Benedetti, Sara; Previtali, Stefano Carlo; Coviello, Silvia; Scarlato, Marina; Cerri, Federica; Di Pierri, Emanuela; Piantoni, Lara; Spiga, Ivana; Fazio, Raffaella; Riva, Nilo; Sora, Maria Grazia Natali; Dacci, Patrizia; Malaguti, Maria Chiara; Munerati, Elisabetta; Grimaldi, Luigi Maria Edoardo; Marrosu, Maria Giovanna; De Pellegrin, Maurizio; Ferrari, Maurizio; Comi, Giancarlo; Quattrini, Angelo; Bolino, Alessandra.

In: Archives of Neurology, Vol. 67, No. 12, 12.2010, p. 1498-1505.

Research output: Contribution to journalArticle

Benedetti, S, Previtali, SC, Coviello, S, Scarlato, M, Cerri, F, Di Pierri, E, Piantoni, L, Spiga, I, Fazio, R, Riva, N, Sora, MGN, Dacci, P, Malaguti, MC, Munerati, E, Grimaldi, LME, Marrosu, MG, De Pellegrin, M, Ferrari, M, Comi, G, Quattrini, A & Bolino, A 2010, 'Analyzing histopathological features of rare Charcot-Marie-Tooth neuropathies to unravel their pathogenesis', Archives of Neurology, vol. 67, no. 12, pp. 1498-1505. https://doi.org/10.1001/archneurol.2010.303
Benedetti, Sara ; Previtali, Stefano Carlo ; Coviello, Silvia ; Scarlato, Marina ; Cerri, Federica ; Di Pierri, Emanuela ; Piantoni, Lara ; Spiga, Ivana ; Fazio, Raffaella ; Riva, Nilo ; Sora, Maria Grazia Natali ; Dacci, Patrizia ; Malaguti, Maria Chiara ; Munerati, Elisabetta ; Grimaldi, Luigi Maria Edoardo ; Marrosu, Maria Giovanna ; De Pellegrin, Maurizio ; Ferrari, Maurizio ; Comi, Giancarlo ; Quattrini, Angelo ; Bolino, Alessandra. / Analyzing histopathological features of rare Charcot-Marie-Tooth neuropathies to unravel their pathogenesis. In: Archives of Neurology. 2010 ; Vol. 67, No. 12. pp. 1498-1505.
@article{57abe69a5ca149cca5c0eb9bd2060820,
title = "Analyzing histopathological features of rare Charcot-Marie-Tooth neuropathies to unravel their pathogenesis",
abstract = "Background: Charcot-Marie-Tooth (CMT) neuropathies are very heterogeneous disorders from both a clinical and genetic point of view. The CMT genes identified so far encode different proteins that are variably involved in regulating Schwann cells and/or axonal functions. However, the function of most of these proteins still remains to be elucidated. Objective: To characterize a large cohort of patients with demyelinating, axonal, and intermediate forms of CMT neuropathy. Design: A cohort of 131 unrelated patients were screened for mutations in 12 genes responsible for CMT neuropathies. Demyelinating, axonal, and intermediate forms of CMT neuropathy were initially distinguished as usual on the basis of electrophysiological criteria and clinical evaluation. A sural nerve biopsy was also performed for selected cases. Accordingly, patients underwent first-level analysis of the genes most frequently mutated in each clinical form of CMT neuropathy. Results: Although our cohort had a particularly high percentage of cases of rare axonal and intermediate CMT neuropathies, we found mutations in 40{\%} of patients. Among identified changes, 7 represented new mutations occurring in the MPZ, GJB1, EGR2, MFN2, NEFL, and HSBP1/HSP27 genes. Histopathological analysis performed in selected cases revealed morphological features, which correlated with the molecular diagnosis and provided evidence of the underlying pathogenetic mechanism. Conclusion: Clinical and pathological analysis of patients with CMT neuropathies contributes to our understanding of the molecular mechanisms of CMT neuropathies.",
author = "Sara Benedetti and Previtali, {Stefano Carlo} and Silvia Coviello and Marina Scarlato and Federica Cerri and {Di Pierri}, Emanuela and Lara Piantoni and Ivana Spiga and Raffaella Fazio and Nilo Riva and Sora, {Maria Grazia Natali} and Patrizia Dacci and Malaguti, {Maria Chiara} and Elisabetta Munerati and Grimaldi, {Luigi Maria Edoardo} and Marrosu, {Maria Giovanna} and {De Pellegrin}, Maurizio and Maurizio Ferrari and Giancarlo Comi and Angelo Quattrini and Alessandra Bolino",
year = "2010",
month = "12",
doi = "10.1001/archneurol.2010.303",
language = "English",
volume = "67",
pages = "1498--1505",
journal = "Archives of Neurology",
issn = "0003-9942",
publisher = "American Medical Association",
number = "12",

}

TY - JOUR

T1 - Analyzing histopathological features of rare Charcot-Marie-Tooth neuropathies to unravel their pathogenesis

AU - Benedetti, Sara

AU - Previtali, Stefano Carlo

AU - Coviello, Silvia

AU - Scarlato, Marina

AU - Cerri, Federica

AU - Di Pierri, Emanuela

AU - Piantoni, Lara

AU - Spiga, Ivana

AU - Fazio, Raffaella

AU - Riva, Nilo

AU - Sora, Maria Grazia Natali

AU - Dacci, Patrizia

AU - Malaguti, Maria Chiara

AU - Munerati, Elisabetta

AU - Grimaldi, Luigi Maria Edoardo

AU - Marrosu, Maria Giovanna

AU - De Pellegrin, Maurizio

AU - Ferrari, Maurizio

AU - Comi, Giancarlo

AU - Quattrini, Angelo

AU - Bolino, Alessandra

PY - 2010/12

Y1 - 2010/12

N2 - Background: Charcot-Marie-Tooth (CMT) neuropathies are very heterogeneous disorders from both a clinical and genetic point of view. The CMT genes identified so far encode different proteins that are variably involved in regulating Schwann cells and/or axonal functions. However, the function of most of these proteins still remains to be elucidated. Objective: To characterize a large cohort of patients with demyelinating, axonal, and intermediate forms of CMT neuropathy. Design: A cohort of 131 unrelated patients were screened for mutations in 12 genes responsible for CMT neuropathies. Demyelinating, axonal, and intermediate forms of CMT neuropathy were initially distinguished as usual on the basis of electrophysiological criteria and clinical evaluation. A sural nerve biopsy was also performed for selected cases. Accordingly, patients underwent first-level analysis of the genes most frequently mutated in each clinical form of CMT neuropathy. Results: Although our cohort had a particularly high percentage of cases of rare axonal and intermediate CMT neuropathies, we found mutations in 40% of patients. Among identified changes, 7 represented new mutations occurring in the MPZ, GJB1, EGR2, MFN2, NEFL, and HSBP1/HSP27 genes. Histopathological analysis performed in selected cases revealed morphological features, which correlated with the molecular diagnosis and provided evidence of the underlying pathogenetic mechanism. Conclusion: Clinical and pathological analysis of patients with CMT neuropathies contributes to our understanding of the molecular mechanisms of CMT neuropathies.

AB - Background: Charcot-Marie-Tooth (CMT) neuropathies are very heterogeneous disorders from both a clinical and genetic point of view. The CMT genes identified so far encode different proteins that are variably involved in regulating Schwann cells and/or axonal functions. However, the function of most of these proteins still remains to be elucidated. Objective: To characterize a large cohort of patients with demyelinating, axonal, and intermediate forms of CMT neuropathy. Design: A cohort of 131 unrelated patients were screened for mutations in 12 genes responsible for CMT neuropathies. Demyelinating, axonal, and intermediate forms of CMT neuropathy were initially distinguished as usual on the basis of electrophysiological criteria and clinical evaluation. A sural nerve biopsy was also performed for selected cases. Accordingly, patients underwent first-level analysis of the genes most frequently mutated in each clinical form of CMT neuropathy. Results: Although our cohort had a particularly high percentage of cases of rare axonal and intermediate CMT neuropathies, we found mutations in 40% of patients. Among identified changes, 7 represented new mutations occurring in the MPZ, GJB1, EGR2, MFN2, NEFL, and HSBP1/HSP27 genes. Histopathological analysis performed in selected cases revealed morphological features, which correlated with the molecular diagnosis and provided evidence of the underlying pathogenetic mechanism. Conclusion: Clinical and pathological analysis of patients with CMT neuropathies contributes to our understanding of the molecular mechanisms of CMT neuropathies.

UR - http://www.scopus.com/inward/record.url?scp=78650111998&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78650111998&partnerID=8YFLogxK

U2 - 10.1001/archneurol.2010.303

DO - 10.1001/archneurol.2010.303

M3 - Article

C2 - 21149811

AN - SCOPUS:78650111998

VL - 67

SP - 1498

EP - 1505

JO - Archives of Neurology

JF - Archives of Neurology

SN - 0003-9942

IS - 12

ER -